Myeloperoxidase is a critical mediator of anthracycline-induced cardiomyopathy.

Autor: Nettersheim FS; Department of Cardiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany. felix.nettersheim@uk-koeln.de.; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany. felix.nettersheim@uk-koeln.de., Schlüter JD; Department of Cardiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany., Kreuzberg W; Department of Cardiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany., Mehrkens D; Department of Cardiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany., Grimm S; Department of Cardiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany., Nemade H; Department of Cardiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany., Braumann S; Department of Cardiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany., Hof A; Department of Cardiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany., Guthoff H; Department of Cardiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany., Peters V; Department of Cardiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany., Hoyer FF; Department of Cardiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany., Kargapolova Y; Department of Cardiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany., Lackmann JW; CECAD, Faculty of Mathematics and Natural Sciences, University of Cologne, Cologne, Germany., Müller S; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany., Pallasch CP; CECAD, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Department I of Internal Medicine, Center for Integrated Oncology (CIO) Köln-Bonn, Cologne, Germany., Hallek M; CECAD, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Department I of Internal Medicine, Center for Integrated Oncology (CIO) Köln-Bonn, Cologne, Germany., Sachinidis A; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.; Institute of Neurophysiology, Faculty of Medicine, University of Cologne, Cologne, Germany., Adam M; Department of Cardiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany., Winkels H; Department of Cardiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany., Baldus S; Department of Cardiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany., Geißen S; Department of Cardiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany., Mollenhauer M; Department of Cardiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany. martin.mollenhauer@uk-koeln.de.; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany. martin.mollenhauer@uk-koeln.de.

Publikováno v: Basic research in cardiology [Basic Res Cardiol] 2023 Sep 01; Vol. 118 (1), pp. 36. Date of Electronic Publication: 2023 Sep 01.

Neutrophil Biomarkers Can Predict Cardiotoxicity of Anthracyclines in Breast Cancer.

Autor: Todorova, Valentina K.^1,2,3,4 (AUTHOR) annjanette.stone@va.gov, Azhar, Gohar² (AUTHOR), Stone, Annjanette⁴ (AUTHOR), Malapati, Sindhu J.^1,3 (AUTHOR), Che, Yingni² (AUTHOR), Zhang, Wei⁵ (AUTHOR), Makhoul, Issam^1,3 (AUTHOR), Wei, Jeanne Y.² (AUTHOR)

Publikováno v: International Journal of Molecular Sciences. Sep2024, Vol. 25 Issue 17, p9735. 21p.

Cardioprotection strategies for anthracycline cardiotoxicity.

Autor: Moreno-Arciniegas A; Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain., Cádiz L; Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain., Galán-Arriola C; Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.; Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain., Clemente-Moragón A; Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.; Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain., Ibáñez B; Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain. bibanez@cnic.es.; Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain. bibanez@cnic.es.; Cardiology Department, IIS-Fundación Jiménez Díaz University Hospital, Madrid, Spain. bibanez@cnic.es.

Publikováno v: Basic research in cardiology [Basic Res Cardiol] 2024 Sep 09. Date of Electronic Publication: 2024 Sep 09.

Cultural Atmosphere as a Component of the Quality of Life in Cities.

Autor: Majer, Andrzej¹ amajer@lodz.home.pl

Publikováno v: Public Governance / Zarządzanie Publiczne. 2020, Vol. 54 Issue 4, p20-34. 15p.

TEATR SPOŁECZNY, INTERKULTUROWY, POSTMIGRANCKI. (Polish)

Autor: Prykowska-Michalak, Karolina, Szymańska, Eliza

Publikováno v: Pamiętnik Teatralny; 2020, Vol. 276 Issue 4, p85-102, 18p